^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

MET amplification + MET Exon 14 mutation

i
Other names: DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase
Entrez ID:
Phase N/A
Lung Cancer Mutation Consortium
Recruiting
Last update posted :
09/12/2023
Initiation :
06/15/2022
Primary completion :
06/15/2024
Completion :
06/15/2025
EGFR • HER-2 • BRAF • ALK • TMB • MET • RET • ROS1 • NTRK
|
BRAF V600E • EGFR mutation • HER-2 amplification • BRAF V600 • MET amplification • ALK rearrangement • MET exon 14 mutation • RET mutation • ROS1 rearrangement • MET mutation • RET rearrangement • MET amplification + MET Exon 14 mutation
Phase 2
Fondazione Ricerca Traslazionale
Unknown status
Last update posted :
10/25/2017
Initiation :
12/01/2014
Primary completion :
06/01/2018
Completion :
12/01/2018
MET • ROS1
|
MET amplification • MET exon 14 mutation • ROS1 positive • MET mutation • MET amplification + MET Exon 14 mutation
|
Xalkori (crizotinib)